ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
The S&P/ASX 200 (ASX:XJO) managed to push higher on Tuesday with AusNet (ASX:AST) and BHP (ASX:BHP) shares back in the headlines.
The S&P/ASX 200 (ASX:XJO) suffered its worst day in months falling 1.9% on Thursday, with small-caps feeling the brunt of the heat.
The S&P/ASX 200 (ASX:XJO) overcame another 8% fall in the iron ore price to deliver a 0.4% gain on Friday as REA (ASX:REA) reported results.
The Resmed CDI (ASX: RMD) share price has been a star performer on the ASX recently. Here are just two ways I look at ResMed.
Global healthcare leader Resmed CDI (ASX: RMD) recorded a 14% increase in quarterly sales upon “incredible demand” and a competitor recall.
The S&P/ASX 200 (ASX: XJO) managed a 0.2% gain on Friday as Rio Tinto (ASX:RIO) and Evolution Mining (ASX:EVN) shares make headlines.
Shares in healthcare giant CSL Limited (ASX: CSL) have made a strong recovery recently. Here’s what could be driving the share price higher.
The S&P/ASX 200 (ASX: XJO) finished 0.1% higher on Friday as markets continued to digest the week’s change of heart from the Federal Reserve.
The ResMed CDI (ASX: RMD) share price is in the spotlight as it released its Q3 update. How will this update affect the ResMed share price?
